Cargando…
Endogenous expression mapping of malignant melanoma by mass spectrometry imaging
BACKGROUND: Currently, only a limited number of molecular biomarkers for malignant melanoma exist. This is the case for both diagnosing the disease, staging, and efficiently measuring the response to therapy by tracing the progression of disease development and drug impact. There is a great need to...
Autores principales: | Sugihara, Yutaka, Rivas, Daniel, Malm, Johan, Szasz, Marcell, Kwon, HoJeong, Baldetorp, Bo, Olsson, Håkan, Ingvar, Christian, Rezeli, Melinda, Fehniger, Thomas E., Marko-Varga, György |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6077138/ https://www.ncbi.nlm.nih.gov/pubmed/30079437 http://dx.doi.org/10.1186/s40169-018-0201-x |
Ejemplares similares
-
Correlation of histopathologic characteristics to protein expression and function in malignant melanoma
por: Welinder, Charlotte, et al.
Publicado: (2017) -
Challenging the heterogeneity of disease presentation in malignant melanoma—impact on patient treatment
por: Marcell Szasz, A., et al.
Publicado: (2018) -
A Protein Deep Sequencing Evaluation of Metastatic Melanoma Tissues
por: Welinder, Charlotte, et al.
Publicado: (2015) -
Biobank integration of large-scale clinical and histopathology melanoma studies within the European Cancer Moonshot Lund Center
por: Malm, Johan, et al.
Publicado: (2018) -
Improved survival prognostication of node-positive malignant melanoma patients utilizing shotgun proteomics guided by histopathological characterization and genomic data
por: Betancourt, Lazaro Hiram, et al.
Publicado: (2019)